Alembic Pharma Reports 4% Revenue Growth; Net Profit at ₹138 Crores in Q3FY25
3rd February 2025, Bengaluru: Alembic Pharmaceuticals Limited reported its consolidated financial results for the third quarter ended 31st December, 2024. Financial Highlights Net Sales increased by 4% to
